Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid.
Puri
B K
BK
Richardson
A J
AJ
D000328:Adult; D002986:Clinical Trials as Topic; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome
D015118:Eicosapentaenoic Acid